Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells - PubMed (original) (raw)
. 2003 Sep;17(9):1726-37.
doi: 10.1210/me.2003-0031. Epub 2003 May 29.
Affiliations
- PMID: 12775765
- DOI: 10.1210/me.2003-0031
Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells
Michael E Wright et al. Mol Endocrinol. 2003 Sep.
Abstract
Androgen-ablation therapy is an effective method for treating prostate cancer. However, prostate tumors that survive long-term androgen-ablation therapy are classified as androgen-independent as they proliferate in the absence of androgens, and they tend to be enriched for neuroendocrine (NE) cells. Androgen withdrawal causes androgen-dependent prostate cancer cells to adopt a pronounced NE phenotype, suggesting that androgen receptor (AR) represses an intrinsic NE transdifferentiation process in prostate cancer cells. In this report we show that short interfering RNA-induced AR silencing induced a NE phenotype that manifested itself in the growth of dendritic-like processes in both the androgen-dependent LNCaP and androgen-independent LNCaP-AI human prostate cancer cells. Western blot analysis revealed that neuronal-specific enolase, a marker of the neuronal lineage, was increased by AR knockdown in LNCaP cells. The expression levels of the neuronal-specific cytoskeletal proteins beta-tubulin III, nestin, and glial acidic fibrillary protein were also characterized in AR knockdown cells. Most interestingly, AR silencing induced beta-tubulin III expression in LNCaP cells, while AR knockdown increased glial acidic fibrillary protein levels in both LNCaP and LNCaP-AI cells. Lastly, AR silencing reduced the proliferative capacity of LNCaP and LNCaP-AI cells. Our data demonstrate that AR actively represses an intrinsic NE transdifferentiation process in androgen-responsive prostate cancer cells and suggest a potential link between AR inactivation and the increased frequency of NE cells in androgen-independent tumors.
Similar articles
- NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ. Jin RJ, et al. Cancer Res. 2004 Aug 1;64(15):5489-95. doi: 10.1158/0008-5472.CAN-03-3117. Cancer Res. 2004. PMID: 15289359 - Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
Yuan TC, Veeramani S, Lin FF, Kondrikou D, Zelivianski S, Igawa T, Karan D, Batra SK, Lin MF. Yuan TC, et al. Endocr Relat Cancer. 2006 Mar;13(1):151-67. doi: 10.1677/erc.1.01043. Endocr Relat Cancer. 2006. PMID: 16601285 - Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
Yuan TC, Veeramani S, Lin MF. Yuan TC, et al. Endocr Relat Cancer. 2007 Sep;14(3):531-47. doi: 10.1677/ERC-07-0061. Endocr Relat Cancer. 2007. PMID: 17914087 Review. - Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
Culig Z, Bartsch G, Hobisch A. Culig Z, et al. Mol Cell Endocrinol. 2002 Nov 29;197(1-2):231-8. doi: 10.1016/s0303-7207(02)00263-0. Mol Cell Endocrinol. 2002. PMID: 12431817 Review.
Cited by
- Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells.
Martinez HD, Hsiao JJ, Jasavala RJ, Hinkson IV, Eng JK, Wright ME. Martinez HD, et al. Genes Cancer. 2011 Oct;2(10):956-78. doi: 10.1177/1947601912436422. Genes Cancer. 2011. PMID: 22701762 Free PMC article. - Neuroendocrine differentiation in prostate cancer.
Sun Y, Niu J, Huang J. Sun Y, et al. Am J Transl Res. 2009 Feb 5;1(2):148-62. Am J Transl Res. 2009. PMID: 19956427 Free PMC article. - Mechanisms mediating androgen receptor reactivation after castration.
Yuan X, Balk SP. Yuan X, et al. Urol Oncol. 2009 Jan-Feb;27(1):36-41. doi: 10.1016/j.urolonc.2008.03.021. Urol Oncol. 2009. PMID: 19111796 Free PMC article. Review. - Case Series: "Silent" Spinal Epidural Metastases in Metastatic Castrate-Resistant Prostate Cancer.
Sabanathan D, Parsonson AO, Park JJ, Gurney H. Sabanathan D, et al. Case Rep Oncol. 2023 Nov 10;16(1):1370-1377. doi: 10.1159/000534685. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 37954126 Free PMC article. - Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression.
Patel N, Itakura T, Jeong S, Liao CP, Roy-Burman P, Zandi E, Groshen S, Pinski J, Coetzee GA, Gross ME, Fini ME. Patel N, et al. PLoS One. 2015 Feb 18;10(2):e0117758. doi: 10.1371/journal.pone.0117758. eCollection 2015. PLoS One. 2015. PMID: 25693195 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials